Anebulo Pharmaceuticals, Inc. (ANEB)
NASDAQ: ANEB · Real-Time Price · USD
0.990
-0.120 (-10.81%)
Dec 20, 2024, 4:00 PM EST - Market closed
Anebulo Pharmaceuticals Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for ANEB stock has a target of 8.00, which predicts an increase of 708.08% from the current stock price of 0.99.
Analyst Consensus: Buy
* Price targets were last updated on Nov 19, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for ANEB is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 0 | 0 | 0 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 3 | 3 | 1 | 1 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Benchmark | Benchmark | Buy Reiterates $8 | Buy | Reiterates | $8 | +708.08% | Nov 19, 2024 |
Benchmark | Benchmark | Buy Reiterates $8 | Buy | Reiterates | $8 | +708.08% | Oct 1, 2024 |
Benchmark | Benchmark | Buy Reiterates $8 | Buy | Reiterates | $8 | +708.08% | Oct 3, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +506.06% | Sep 25, 2023 |
Maxim Group | Maxim Group | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +506.06% | Sep 21, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.22
from -0.32
EPS Next Year
-0.66
from -0.22
Revenue Forecast
Revenue | 2025 | 2026 |
---|---|---|
High | n/a | n/a |
Avg | n/a | n/a |
Low | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
EPS Forecast
EPS | 2025 | 2026 |
---|---|---|
High | -0.23 | -0.68 |
Avg | -0.22 | -0.66 |
Low | -0.22 | -0.64 |
EPS Growth
EPS Growth | 2025 | 2026 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.